Showing Form 4 filings for RVMD
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Revolution Medicines, Inc.
Price
$207.32
Shares
765
Ownership
51,776
Value/Share
Cislini Jeff
SVP, GC
Industry